The Union for International Cancer Control (UICC) and the American Joint Committee on Cancer (AJCC) gastric cancer TNM staging system (8th edition) explanation and elaboration

陕飞,李子禹,张连海,李双喜,贾永宁,苗儒林,薛侃,李浙民,高翔宇,王胤奎,闫超,李沈,季加孚

DOI: https://doi.org/10.19538/j.cjps.issn1005-2208.2017.01.05

2017-01-01

Abstract:The Union for International Cancer Control (UICC) and the American Joint Committee on Cancer (AJCC) have issued the Eighth Edition of TNM staging system manual in October 2016. The updated version made evidence-based, prominent revisions in cancer stage classification system. Specifically, the old TNM staging system based on post-operative pathological examination was replaced by a more sophisticated staging system including clinical staging (cTNM), pathological staging (pTNM), and neo-adjuvant post-treatment staging (ypTNM). These revisions help oncologists and other clinicians better determine the stage of gastric cancer patients according to their conditions and treatments. Consequentially, appropriate individualized anti-cancer treatment could be made possible for each patient. Also, the Eighth Edition revised the guidance in staging gastroesophageal junction cancer and cardia cancer. Another update is N3a and N3b, separated from N3, work as two independent groups in staging system. Comparing to the Seventh Edition, some adjustment was made in sub-classifying patients of stage III. The usefulness and appropriateness of the new updates need clinical validation around the world. Although a risk prediction model incorporating the recent advancement of molecular biology has not been developed as expected, the Eighth Edition provides a useful tool for clinicians in the transition to precision treatment for gastric cancer.